Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (681-690 of 779) with videos related to

Pageof 78
Sort By:
Journal for Immunotherapy of Cancer|August 24, 2023
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockadeMinglei Wang, Yiheng Huang, Minxin Chen, et al.
Molecular Oncology|February 8, 2024
Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLCLi Li, Kewen He, Tao Zhou, et al.
Cancer Communications (London, England)|January 4, 2022
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancerBo Cheng, Kaikai Ding, Pengxiang Chen, et al.
Frontiers in Oncology|September 12, 2022
Potential <sup>18</sup>F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and ChemoradiotherapyLi Li, Ning Liu, Hui Zhang, et al.
American Journal of Clinical Oncology|December 7, 2006
Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancerLing Li, Jinming Yu, Ligang Xing, et al.
JAMA Dermatology|June 1, 2022
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical TrialHanxi Zhao, Wanqi Zhu, Xianguang Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2023
Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4Jinli Pei, Kai Cheng, Tianxin Liu, et al.
Cell Death Discovery|March 15, 2024
Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based studyYawen Sun, Wenjuan Liu, Mu Su, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2013
Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancerShuanghu Tiger Yuan, Vicki L Ellingrod, Matthew Schipper, et al.
Medicine|October 3, 2019
Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcomeMan Hu, Peng Xie, Nancy Y Lee, et al.
Pageof 78

Showing results (681-690 of 779) with videos related to

Sort By:
Pageof 78
Journal for Immunotherapy of Cancer|August 24, 2023
Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockadeMinglei Wang, Yiheng Huang, Minxin Chen, et al.
Molecular Oncology|February 8, 2024
Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLCLi Li, Kewen He, Tao Zhou, et al.
Cancer Communications (London, England)|January 4, 2022
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancerBo Cheng, Kaikai Ding, Pengxiang Chen, et al.
Frontiers in Oncology|September 12, 2022
Potential <sup>18</sup>F-RGD PET/CT and DCE-MRI Imaging-Based Biomarkers for Postoperative Survival Prediction Among Patients With Newly Diagnosed Glioblastoma Treated With Bevacizumab and ChemoradiotherapyLi Li, Ning Liu, Hui Zhang, et al.
American Journal of Clinical Oncology|December 7, 2006
Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancerLing Li, Jinming Yu, Ligang Xing, et al.
JAMA Dermatology|June 1, 2022
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical TrialHanxi Zhao, Wanqi Zhu, Xianguang Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2023
Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4Jinli Pei, Kai Cheng, Tianxin Liu, et al.
Cell Death Discovery|March 15, 2024
Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based studyYawen Sun, Wenjuan Liu, Mu Su, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2013
Genetic variations in TGFβ1, tPA, and ACE and radiation-induced thoracic toxicities in patients with non-small-cell lung cancerShuanghu Tiger Yuan, Vicki L Ellingrod, Matthew Schipper, et al.
Medicine|October 3, 2019
Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcomeMan Hu, Peng Xie, Nancy Y Lee, et al.
Pageof 78